April 5, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

April 5, 2018 at 8:15 AM EDT PDF Version WALTHAM, Massachusetts – April 5, 2018 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program.    Duchenne muscular dystrophy (Duchenne) is the most common genetic disorder diagnosed in... Read more

March 28, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif., March 28, 2018 /PRNewswire/ — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled... Read more

March 27, 2018 Clinical Research/Diagn. Environ, Ag./Food & Bev Life Science Tools

Pacific Biosciences Announces Ten-Unit Sequel System Order for Annoroad

MENLO PARK, Calif., March 27, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), the leader in long-read, high-resolution sequencing, today announced a purchase order for 10 PacBio® Sequel® Systems that are expected to be installed at Annoroad’s designated facility within the next several months, enhancing Annoroad’s large-scale genomic service capabilities across various fields... Read more

March 26, 2018 Clinical Research/Diagn. M&A, Partnerships

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China

26 March 2018 San Diego, Calif., and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY® System for companion diagnostics and pharmacogenetic testing in China. As a leading pharmaceutical... Read more

March 22, 2018 Clinical Research/Diagn. PR/Corporate

Precipio Restructures Capitalization Table

INVESTORS TO CONVERT PREFERRED SHARES AND EXERCISE WARRANTS NEW HAVEN, Conn., March 22, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), in an 8-K issued today announced an agreement with investors in certain 2017 underwritten and registered direct offerings, to convert their preferred shares and exercise a substantial portion of their warrants. The benefit to common stockholders... Read more

March 21, 2018 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools Product Launch

Bio-Techne Expands RNAscope® ISH Automation – Facilitating Drug Discovery and Development

New and updated assays increase application areas and improve performance MINNEAPOLIS, March 21, 2018 /PRNewswire/ — Bio-Techne has expanded the automation capabilities of its popular Advanced Cell Diagnostics (ACD)-branded RNAscope® in situ hybridization (ISH) technology with the launch of several new and updated assays. The developments increase both access to, and use of, RNAscope and improve overall robustness and ease-of-use.... Read more

March 20, 2018 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection

Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity March 20, 2018 06:00 AM Pacific Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration with DestiNA Genomics, a manufacturer of patented reagents for nucleic acid detection.... Read more

March 19, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Human Longevity, Inc. Hires Former Ancestry Executive, Scott Sorensen, As New Chief Technology Officer

INDUSTRY LEADER BRINGS 25 YEARS OF EXPERTISE IN SOFTWARE PRODUCTS AND SERVICES TO HELP HLI SCALE BUSINESS SAN DIEGO, March 19, 2018 /PRNewswire/ — Human Longevity, Inc. (HLI) – the genomics-powered health intelligence company – announced today that Scott Sorensen is joining the leadership team as Chief Technology Officer, reporting to J. Craig Venter, Ph.D., Co-Founder, Chairman and CEO. Sorensen joins... Read more

March 19, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools PR/Corporate

Luna DNA Expands Leadership and Advisory Board, Adding New Pedigree From Illumina

Three industry leaders join company ranks to drive genomic discovery SAN DIEGO, March 19, 2018 /PRNewswire/ — 9:30 a.m. PT — Luna DNA, the first community owned genomic and medical research database, today announced the addition of three new members to its leadership team. The key hires in the VP of marketing and VP of business strategy and operation... Read more